Employment Verification for Akebia Therapeutics.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a biopharmaceutical company that focuses on the development and commercialization of drugs for patients with kidney disease. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts. Akebia’s lead drug candidate is Vadadustat, an oral therapy designed to treat anemia caused by chronic kidney disease. The drug is currently in Phase 3 clinical trials and has been granted fast track designation by the U.S. Food and Drug Administration. In addition to Vadadustat, Akebia has several other drug candidates in its pipeline, including AKB-5169, which is being developed for the treatment of inflammatory bowel disease, and AKB-4924, which is being studied for the treatment of idiopathic pulmonary fibrosis. Akebia has strategic partnerships and collaborations with a number of global pharmaceutical companies, including Otsuka Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and Vifor Pharma. The company is led by Chief Executive Officer John Butler, who has more than 25 years of experience in the biopharmaceutical industry. Akebia is publicly traded on the Nasdaq Global Market under the ticker symbol AKBA.

The information on this page is not an endorsement of Truv’s services by Akebia Therapeutics and is meant to be purely informational.

Verify Akebia Therapeutics Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee, learn more.